Erratum: Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer(J Clin Invest. (2019)129:6 (2595-2595) DOI:10.1172/JCI129688)

4Citations
Citations of this article
133Readers
Mendeley users who have this article in their library.

Abstract

Stanford University School of Medicine recently notified the JCI of concerns regarding Figure 4, A and C, and indicated that the original source data for these figures could not be located. In accordance with the institutional recommendation, the JCI is retracting this article.

Cite

CITATION STYLE

APA

Kohrt, H. E., Houot, R., Weiskopf, K., Goldstein, M. J., Scheeren, F., Czerwinski, D., … Levy, R. (2019, June 3). Erratum: Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer(J Clin Invest. (2019)129:6 (2595-2595) DOI:10.1172/JCI129688). Journal of Clinical Investigation. American Society for Clinical Investigation. https://doi.org/10.1172/JCI61226

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free